Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.neulandlabs.com | |
Market Cap | 2,096.66 Cr. | |
Enterprise Value(EV) | 2,269.81 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 78.53 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 20.81 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 31.71 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 715.96 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 2.28 | Calculated using Price: 1,634.20 |
Dividend Yield | 0.31 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.28 Cr. | 12,829,889 Shares |
FaceValue | 10 | |
Company Profile | ||
Neuland is a quality conscious, research driven, reliable source of active pharmaceutical ingredients. Neuland has two world-class API manufacturing facilities close to the city of Hyderabad, capable in handling complex and hazardous reactions. Safety aspects have been given utmost significance may it be plant installation, equipment, systems and personnel to ensure smooth productivity. Dedicated team of manufacturing with incorporation of latest production techniques guarantees delivery of latest intermediate and product to our customers across the globe. |
1 Day |
|
+0.08% |
1 Week |
|
-1.69% |
1 Month |
|
-0.14% |
3 Month |
|
-1.72% |
6 Month |
|
+32.12% |
1 Year |
|
+40.54% |
2 Year |
|
-17.10% |
5 Year |
|
+127.21% |
10 Year |
|
+1740.69% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 24.14 | 11.24 | 15.64 | 22.34 | 5.02 | 3.48 | 2.30 | 10.79 | 7.85 | |
Return on Capital Employed (%) | 18.99 | 15.75 | 18.57 | 15.98 | 4.07 | 3.99 | 7.85 | 12.81 | 9.44 | |
Return on Assets (%) | 5.89 | 3.20 | 5.23 | 6.65 | 1.23 | 1.49 | 1.37 | 6.31 | 4.71 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 124 | 161 | 187 | 546 | 558 | 699 | 710 | 786 | 841 | 883 | |
Non Curr. Liab. | 52 | 55 | 69 | 54 | 146 | 104 | 163 | 170 | 180 | 164 | |
Curr. Liab. | 307 | 295 | 268 | 286 | 367 | 327 | 358 | 369 | 363 | 378 | |
Minority Int. | 0 | 0 | |||||||||
Equity & Liab. | 483 | 512 | 524 | 886 | 1,071 | 1,130 | 1,231 | 1,325 | 1,383 | 1,424 | |
Non Curr. Assets | 196 | 196 | 210 | 511 | 624 | 677 | 716 | 775 | 801 | 805 | |
Curr. Assets | 288 | 316 | 314 | 375 | 447 | 453 | 515 | 550 | 583 | 620 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 483 | 512 | 524 | 886 | 1,071 | 1,130 | 1,231 | 1,325 | 1,383 | 1,424 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 466 | 469 | 510 | 579 | 527 | 667 | 763 | 937 | 951 | 1,040 | |
Other Income | 3 | 1 | 2 | 1 | 5 | 3 | 4 | 16 | 2 | 2 | |
Total Income | 469 | 470 | 512 | 580 | 532 | 670 | 767 | 953 | 953 | 1,042 | |
Total Expenditure | -395 | -403 | -430 | -473 | -477 | -608 | -661 | -790 | -808 | -849 | |
PBIDT | 74 | 67 | 82 | 108 | 55 | 62 | 106 | 163 | 145 | 193 | |
Interest | -25 | -27 | -24 | -21 | -19 | -16 | -22 | -18 | -14 | -12 | |
Depreciation | -15 | -15 | -16 | -19 | -22 | -26 | -31 | -40 | -49 | -52 | |
Taxation | -8 | -9 | -15 | -20 | -2 | -4 | -37 | -25 | -18 | -29 | |
Exceptional Items | |||||||||||
PAT | 27 | 16 | 27 | 47 | 12 | 16 | 16 | 81 | 64 | 101 | |
Minority Interest | 0 | 0 | 0 | ||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 27 | 16 | 27 | 47 | 12 | 16 | 16 | 81 | 64 | 101 | |
Adjusted EPS | 33 | 18 | 31 | 53 | 14 | 13 | 13 | 63 | 50 | 78 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 26 | 49 | 13 | 45 | 39 | 11 | 70 | 57 | 189 | 59 | |
Cash Fr. Inv. | -7 | -10 | -14 | -20 | -42 | -116 | -77 | -49 | -84 | -94 | |
Cash Fr. Finan. | -20 | -39 | 1 | -24 | 0 | 105 | 12 | -5 | -114 | 38 | |
Net Change | -1 | 0 | 0 | 1 | -4 | 0 | 5 | 3 | -9 | 3 | |
Cash & Cash Eqvt | 1 | 1 | 1 | 2 | 3 | 3 | 8 | 11 | 2 | 5 |
Sat, 18 Feb 2023
Intimation Of S&P Global ESG Score 2022 We would like to inform that in our first endeavour to evaluate our environmental social and governance (ESG) efforts our Company was awarded an ESG score of 48 out of 100 by S&P Global. The Companys score placed it in the 92nd percentile among 343 companies considered as industry peers during 2021 and 2022. The average ESG score in the said category during the defined period was 21.Neuland is committed to integrating sustainability and ESG priorities across its operations. |
Fri, 17 Feb 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript Transcript of the Earnings call conducted on February 14 2023 |
Tue, 14 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Copy of Newspaper Publication Q3 FY23 financial results |
Mon, 20 Mar 2023 |
|
|
|
|
|